Analysis of immune responses in genital tracts of mice immunised with purified ribosomal fractions of Neisseria gonorrhoeae
- PMID: 6430462
- PMCID: PMC1046313
- DOI: 10.1136/sti.60.4.219
Analysis of immune responses in genital tracts of mice immunised with purified ribosomal fractions of Neisseria gonorrhoeae
Abstract
Immunisation of ddY mice with the purified ribosomal fraction of Neisseria gonorrhoeae was found to protect against intravaginal challenge with homologous organisms. This protection correlated with the presence of bactericidal antibody to purified ribosomal fraction in serum as well as in vaginal secretions. Analysis of the vaginal fluids from control mice and those immunised with purified ribosomal fraction showed that the enhanced elimination of gonococci in immune mice might be because of an early response of leucocytes generated by the reaction mediated by antibody and complement. Absorption studies showed that there was at least one major protective antigen in purified ribosomal fraction, other than cell surface substances such as lipopolysaccharide, outer membrane proteins, and pili. Bactericidal assays mediated by antibody and complement showed that matched samples of serum and vaginal fluid from immune mice had comparable gonococcidal activity, which was augmented by the effect of progesterone. Although delayed hypersensitivity was produced in immune mice that were resistant to N gonorrhoeae, the exact role of cellular immunity could not be clarified in this study. These results suggest that antibody to purified ribosomal fraction plays a major part in protection against gonococcal infection in the genital tract, and that such protection may entail both cellular immunity and hormonal changes.
Similar articles
-
Intranasal administration of recombinant Neisseria gonorrhoeae transferrin binding proteins A and B conjugated to the cholera toxin B subunit induces systemic and vaginal antibodies in mice.Infect Immun. 2005 Jul;73(7):3945-53. doi: 10.1128/IAI.73.7.3945-3953.2005. Infect Immun. 2005. PMID: 15972481 Free PMC article.
-
Microencapsulated IL-12 Drives Genital Tract Immune Responses to Intranasal Gonococcal Outer Membrane Vesicle Vaccine and Induces Resistance to Vaginal Infection with Diverse Strains of Neisseria gonorrhoeae.mSphere. 2023 Feb 21;8(1):e0038822. doi: 10.1128/msphere.00388-22. Epub 2022 Dec 20. mSphere. 2023. PMID: 36537786 Free PMC article.
-
Meningococcal vaccine 4CMenB elicits a robust cellular immune response that targets but is not consistently protective against Neisseria gonorrhoeae during murine vaginal infection.mSphere. 2025 May 27;10(5):e0094024. doi: 10.1128/msphere.00940-24. Epub 2025 Apr 16. mSphere. 2025. PMID: 40237483 Free PMC article.
-
Mucosal immunity in the genital tract: prospects for vaccines against sexually transmitted diseases--a review.Am J Reprod Immunol. 1999 Jul;42(1):58-63. doi: 10.1111/j.1600-0897.1999.tb00466.x. Am J Reprod Immunol. 1999. PMID: 10429768 Review.
-
Strategies for mimicking Neisserial saccharide epitopes as vaccines.Int Rev Immunol. 2001;20(2):229-50. doi: 10.3109/08830180109043036. Int Rev Immunol. 2001. PMID: 11878767 Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources